Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Amgen To Enhance Rare Disease Franchise With $27.8bn Horizon Takeover
Wins Three-Horse Race With Sanofi And J&J
Dec 12 2022
•
By
Ayisha Sharma
Amgen Plans To Expand The Global Footprint For Uplizna and Tepezza • Source: Shutterstock
More from Deals
More from Business